EMCYTE

EmCyte Corporation is leading the way in Autologous Platelet Rich Plasma and Progenitor Stem Cell Biologics... PurePRP® SupraPhysiologic (PurePRP® SP) is a proprietary form of autologous platelet rich plasma developed by EmCyte Corporation. It contains a complex composition of cellular components derived from your blood biologic that can be used to treat and repair a host of injuries and conditions. It is the cornerstone of the consortium of regenerative therapies used in modern medicine and rapidly becoming a standard of care. It's chosen over surgery for many conditions, ranging from degenerative joint disease, to tendon and ligament injuries because its regenerative power is shown to play an adjunctive role in clinical outcomes. It is unique in that it is the only point of care system that selectively removes wound inhibiting factors while concentrating regenerative cellular components. This powerful capability distinguishes the PURE SupraPhysiologic brand, making it the most..

Also known as: EmCyte Corporation

Primary location: Fort Myers United States